These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11084914)

  • 1. Flexible docking of peptide ligands to proteins.
    Desmet J; De Maeyer M; Spriet J; Lasters I
    Methods Mol Biol; 2000; 143():359-76. PubMed ID: 11084914
    [No Abstract]   [Full Text] [Related]  

  • 2. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computing the structure of bound peptides. Application to antigen recognition by class I major histocompatibility complex receptors.
    Rosenfeld R; Zheng Q; Vajda S; DeLisi C
    J Mol Biol; 1993 Dec; 234(3):515-21. PubMed ID: 8254656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of affinity peptide ligand by flexible docking simulation.
    Liu FF; Wang T; Dong XY; Sun Y
    J Chromatogr A; 2007 Mar; 1146(1):41-50. PubMed ID: 17298835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The architecture of protein-ligand binding sites revealed through template-assisted intramolecular peptide-peptide interactions.
    Yu C; Malesevic M; Jahreis G; Schutkowski M; Fischer G; Schiene-Fischer C
    Angew Chem Int Ed Engl; 2005 Feb; 44(9):1408-12. PubMed ID: 15666425
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward the fast blind docking of a peptide to a target protein by using a four-body statistical pseudo-potential.
    Aita T; Nishigaki K; Husimi Y
    Comput Biol Chem; 2010 Feb; 34(1):53-62. PubMed ID: 19939735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mining: self-consistent design on flexible protein-peptide docking and transferable binding affinity potential.
    Liu Z; Dominy BN; Shakhnovich EI
    J Am Chem Soc; 2004 Jul; 126(27):8515-28. PubMed ID: 15238009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities.
    Jayalakshmi V; Rama Krishna N
    J Magn Reson; 2004 May; 168(1):36-45. PubMed ID: 15082247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated flexible docking of ligands into flexible synthetic receptors using forward and inverse docking strategies.
    Kämper A; Apostolakis J; Rarey M; Marian CM; Lengauer T
    J Chem Inf Model; 2006; 46(2):903-11. PubMed ID: 16563022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pso@autodock: a fast flexible molecular docking program based on Swarm intelligence.
    Namasivayam V; Günther R
    Chem Biol Drug Des; 2007 Dec; 70(6):475-84. PubMed ID: 17986206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "In situ cross-docking" to simultaneously address multiple targets.
    Sotriffer CA; Dramburg I
    J Med Chem; 2005 May; 48(9):3122-5. PubMed ID: 15857117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-ligand docking: current status and future challenges.
    Sousa SF; Fernandes PA; Ramos MJ
    Proteins; 2006 Oct; 65(1):15-26. PubMed ID: 16862531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
    Zacharias M
    Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking macromolecules with flexible segments.
    Bastard K; Thureau A; Lavery R; Prévost C
    J Comput Chem; 2003 Nov; 24(15):1910-20. PubMed ID: 14515373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LigEvolutioner, a new strategy for modification and optimization of lead compounds in receptor/ligand complexes.
    Zhou P; Tian F; Shang Z
    Chem Biol Drug Des; 2008 Dec; 72(6):525-32. PubMed ID: 19090919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of modified peptides, potent inhibitors of the xWNT8 and hWNT8 proteins.
    Voronkov AE; Baskin II; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2008 Apr; 26(7):1179-87. PubMed ID: 18296089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A universal TANGO?
    Pande VS
    Nat Biotechnol; 2004 Oct; 22(10):1240-1. PubMed ID: 15470460
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing protein flexibility in docking and its applications.
    B-Rao C; Subramanian J; Sharma SD
    Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pinpointing anthrax-toxin inhibitors.
    Glick M; Grant GH; Richards WG
    Nat Biotechnol; 2002 Feb; 20(2):118-9. PubMed ID: 11821849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.